Dr. James Ip
Claim this profileNew York Presbyterian Hospital/Cornell University
Studies Arrhythmia
Studies Bradycardia
7 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials James Ip is currently running
CCM Device
for Heart Failure
The goal of this clinical trial is to demonstrate that the OPTIMIZER® Integra CCM-D System (the "CCM-D System") can safely and effective convert induced ventricular fibrillation (VF) and spontaneous ventricular tachycardia and/or ventricular fibrillation (VT/VF) episodes in subjects with Stage C or D heart failure who remain symptomatic despite being on guideline-directed medical therapy (GDMT), are not indicated for cardiac resynchronization therapy (CRT), and have heart failure with reduced left ventricular ejection fraction (LVEF ≤40%). Eligible subjects will be implanted with the CCM-D System. A subset of subjects will be induced into ventricular fibrillation "on the table" in the implant procedure room. During the follow-up period, inappropriate shock rate and device-related complications will be evaluated. The follow-up period is expected to last at least two years.
Recruiting1 award N/A8 criteria
Adenosine
for Premature Ventricular Contractions
Unblinded, controlled, non-randomized, mechanistic study to determine whether physiological mechanisms underlying PVC are sensitive to adenosine. One hundred subjects undergoing clinically-indicated, standard-of-care cardiac electrophysiology study (EPS) procedure for PVCs will receive adenosine and/or verapamil to learn if their arrhythmias are inducible similarly to sustained ventricular tachycardia.
Recruiting5 awards Phase 44 criteria
More about James Ip
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments James Ip has experience with
- Aveir DR Leadless Pacemaker System
- Aveir Leadless Pacemaker System
- Aveir VR Leadless Pacemaker System
- WiSE System
- TYRX™ Absorbable Antibacterial Envelope
- OPTIMIZER® Integra CCM-D System
Breakdown of trials James Ip has run
Arrhythmia
Bradycardia
Slow Heart Rate
Cardiac Pacemaker
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does James Ip specialize in?
James Ip focuses on Arrhythmia and Bradycardia. In particular, much of their work with Arrhythmia has involved treating patients, or patients who are undergoing treatment.
Is James Ip currently recruiting for clinical trials?
Yes, James Ip is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that James Ip has studied deeply?
Yes, James Ip has studied treatments such as Aveir DR Leadless Pacemaker System, Aveir Leadless Pacemaker System, Aveir VR Leadless Pacemaker System.
What is the best way to schedule an appointment with James Ip?
Apply for one of the trials that James Ip is conducting.
What is the office address of James Ip?
The office of James Ip is located at: New York Presbyterian Hospital/Cornell University, New York, New York 10021 United States. This is the address for their practice at the New York Presbyterian Hospital/Cornell University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.